Cost-Effectiveness of Eplerenone in NYHA Class II Chronic Heart Failure Patients With Reduced LVEF: An Analysis for Greece
ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s107831
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Informa UK Limited